Evidence map›Paper›PMID 35948367›Full record

ArticleLife science alliance2022

Islet Gene View-a tool to facilitate islet research.

Olof Asplund, Petter Storm, Vikash Chandra, Gad Hatem, Emilia Ottosson-Laakso, Dina Mansour-Aly, Ulrika Krus, Hazem Ibrahim, Emma Ahlqvist, Tiinamaija Tuomi and 13 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Nardilysin regulatesBiochemistry and biophysics reports · 2026
    Article
  4. Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 5 countries.

Olof AsplundDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.ORCID 0000-0001-8449-8907
Petter StormDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Vikash ChandraStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-2713-1831
Gad HatemDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Emilia Ottosson-LaaksoDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Dina Mansour-AlyDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Ulrika KrusDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Hazem IbrahimStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-0165-2660
Emma AhlqvistDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Tiinamaija TuomiDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.ORCID 0000-0002-8306-6202
Erik RenströmDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Olle KorsgrenDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Nils WierupDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Mark IbbersonVital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Michele SolimenaPaul Langerhans Institute Dresden of the Helmholtz Center, Munich at University Hospital Carl Gustav Carus and Faculty of Medicine, TU Dresden, Dresden, Germany.
Piero MarchettiDepartment of Clinical and Experimental Medicine, Cisanello, University Hospital, University of Pisa, Pisa, Italy.ORCID 0000-0003-4907-0635
Claes WollheimDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Isabella ArtnerDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Hindrik MulderDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Ola HanssonDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.ORCID 0000-0002-7394-7639
Timo OtonkoskiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0001-9190-2496
Leif GroopDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Rashmi B PrasadDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden rashmi.prasad@med.lu.se.ORCID 0000-0002-4400-6741
Lund University · SEUniversity of Helsinki · FIDeutsches Diabetes-Zentrum e.V. · DESIB Swiss Institute of Bioinformatics · CHUniversity of Geneva · CHUniversity of Pisa · ITUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterization of gene expression in pancreatic islets and its alteration in type 2 diabetes (T2D) are vital in understanding islet function and T2D pathogenesis. We leveraged RNA sequencing and genome-wide genotyping in islets from 188 donors to create the Islet Gene View (IGW) platform to make this information easily accessible to the scientific community. Expression data were related to islet phenotypes, diabetes status, other islet-expressed genes, islet hormone-encoding genes and for expression in insulin target tissues. The IGW web application produces output graphs for a particular gene of interest. In IGW, 284 differentially expressed genes (DEGs) were identified in T2D donor islets compared with controls. Forty percent of DEGs showed cell-type enrichment and a large proportion significantly co-expressed with islet hormone-encoding genes; glucagon (<i>GCG</i>, 56%), amylin (<i>IAPP</i>, 52%), insulin (<i>INS</i>, 44%), and somatostatin (<i>SST</i>, 24%). Inhibition of two DEGs, <i>UNC5D</i> and <i>SERPINE2</i>, impaired glucose-stimulated insulin secretion and impacted cell survival in a human β-cell model. The exploratory use of IGW could help designing more comprehensive functional follow-up studies and serve to identify therapeutic targets in T2D.

Indexed as

Diabetes Mellitus, Type 2Islets of LangerhansGlucagonHumansInsulinSerpin E2GlucagonInsulinSerpin E2

Identifiers

PMID35948367
PMCPMC9366203
OpenAlexW4290990031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.